Rankings
▼
Calendar
GPCR Q1 2023 Earnings — Structure Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
GPCR
Structure Therapeutics Inc.
$3B
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$20M
Net Income
-$18M
EPS (Diluted)
$-0.48
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$20M
Free Cash Flow
-$20M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$247M
Total Liabilities
$11M
Stockholders' Equity
$236M
Cash & Equivalents
$126M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$20M
-$13M
-51.7%
Net Income
-$18M
-$13M
-37.4%
← FY 2023
All Quarters
Q2 2023 →